Open-Label, Multicenter, Randomized, Phase 2 Study of a Recombinant Human Anti-VEGFR-2 Monoclonal Antibody, IMC-1121B in Combination with Platinum-based Chemotherapy versus Platinum-based Chemotherapy Alone as First-line Treatment of Patients with Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)

Disease Types: Non-Small Cell Lung Cancer,  NSCLC- 1st Line Locally Adv

Protocol Number: USON09179

Available at: Baptist Hospital,  Baptist Medical Arts Building, East Tower,  Baptist Medical Arts Building, East Tower,  S. Miami Hospital Medical Arts Bldg.

Contact:
Elizabeth Groh, BSN, RN
Director of Clinical Research
Advanced Medical Specialties, LLC
8940 North Kendall Drive, Suite 300E
Miami, FL33176
Office 305-728-1882
Fax 305-279-6880
.(JavaScript must be enabled to view this email address)